Skip to main content

H.R. 1966

Enacted

Henrietta Lacks Enhancing Cancer Research Act of 2019

Introduced 3/28/2019•116th Congress•House

Latest Action

Became Public Law No: 116-291.

1/5/2021

Summary

Henrietta Lacks Enhancing Cancer Research Act of 2019

This bill requires the Government Accountability Office to complete a study reviewing how federal agencies address barriers to participation in federally-funded cancer clinical trials by individuals from underrepresented populations and provide recommendations for addressing such barriers.

Public Law • 1/5/2021

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health
CancerCongressional oversightDrug safety, medical device, and laboratory regulationGovernment studies and investigationsMedical researchMinority healthPublic participation and lobbying

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (79)

Party Breakdown

70
Democrats
9
Republicans
0
Independents

Sponsor

R[
Rep. Cummings, Elijah E. [D-MD-7]

Democrat • MD-7

Sponsored 3/28/2019

Cosponsors (78)

R[
Rep. Sarbanes, John P. [D-MD-3]

D-MD-3

Joined 3/28/2019

R[
Rep. Fudge, Marcia L. [D-OH-11]

D-OH-11

Joined 6/19/2019

R[
R[
R[
Rep. Kelly, Robin L. [D-IL-2]

D-IL-2

Joined 6/19/2019

Enacted into Law

Public Law 116-291

View on Congress.gov

Bill Journey

Originated in the House

Introduced

March 28, 2019

Committee Review

December 18, 2020

Floor Debate

December 9, 2020

Passed Chamber

December 9, 2020

Other Chamber

December 20, 2020

President

December 24, 2020

Enacted into Law

January 5, 2021

Became Public Law No: 116-291.

Text Versions (5)

Referred in Senate12/10/2020
Engrossed in House12/9/2020
Introduced in House3/28/2019

Details

Bill TypeHR
Current StatusEnacted
Cosponsors78